Gene Mutation Potential Target for Diagnosis, Treatment of Insulinoma

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
Chinese researchers from Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, BGI and other institutes identified the recurrent T372R mutation in the transcription factor YY1 (Yin Yang 1) are related with insulinoma oncogenesis, implicating a potential marker for the diagnosis and treatment of functional pancreatic neuroendocrine tumors (PNETs). The latest study was published online in Nature Communications.

Pancreatic neuroendocrine tumors are classified into functional and nonfunctional tumors by hormone secretion and clinical symptoms. Functional PNETs are mainly represented by insulinoma, which secrete insulin independent of glucose and cause hypoglycemia. The major genetic alterations in insulinomas are still unknown.

http://www.sciencedaily.com/releases/2013/12/131211104610.htm
 
Status
Not open for further replies.
Back
Top